Early Experience Implementing Long-Acting Injectable Cabotegravir/Rilpivirine for Human Immunodeficiency Virus-1 Treatment at a Ryan White-Funded Clinic in the US South

Promise, perils and cautious optimism

(2022) Morgan M. Philbin et al.   Current Opinion in HIV and AIDS

Equity in access to long-acting injectables in the USA

(2022) J Carlo Hojilla et al.   Lancet HIV

A Qualitative Exploration of Women's Interest in Long-Acting Injectable Antiretroviral Therapy Across Six Cities in the Women's Interagency HIV Study: Intersections with Current and Past Injectable Medication and Substance Use

(2021) Morgan M. Philbin et al.   AIDS PATIENT CARE AND STDS

Factors associated with interest in a long-acting HIV regimen: perspectives of people living with HIV and healthcare providers in four European countries

(2021) Babatunde Akinwunmi et al.   SEXUALLY TRANSMITTED INFECTIONS

Predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine

(2021) Amy G. Cutrell et al.   AIDS

Long-acting cabotegravir plus rilpivirine for treatment in adults with HIV-1 infection: 96-week results of the randomised, open-label, phase 3 FLAIR study

(2021) Chloe Orkin et al.   Lancet HIV

Long-acting cabotegravir + rilpivirine for HIV-1 treatment

(2021) Susan Swindells et al.   AIDS

Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

(2021) Raphael J. Landovitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Acting Injectable ART and PrEP Among Women in Six Cities Across the United States: A Qualitative Analysis of Who Would Benefit the Most

(2021) Morgan M. Philbin et al.   AIDS AND BEHAVIOR

Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016

(2020) Julia L. Marcus et al.   JAMA Network Open

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy

(2020) Giuliano Rizzardini et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Ending the HIV Epidemic

(2019) Anthony S. Fauci et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Challenges of reaching 90–90–90 in the Southern United States

(2019) Jonathan A. Colasanti et al.   Current Opinion in HIV and AIDS

The Time Is Now to End the HIV Epidemic

(2019) Brett P. Giroir   AMERICAN JOURNAL OF PUBLIC HEALTH

Prevention of HIV-1 Infection with Early Antiretroviral Therapy

(2011) Myron S. Cohen et al.   NEW ENGLAND JOURNAL OF MEDICINE